Siemens Siemens.com Siemens diagnostics.com
Search Our Knowledge Base
Physicians Laboratory Professionals Healthcare Administrators Patients
 
Home


Surgical Revascularization


High-risk patients with LV systolic dysfunction, patients with diabetes mellitus and those with two-vessel disease with severe proximal LAD involvement of three-vessel or left main disease should be considered for Coronary Artery Bypass Graft (CABG). Compared with these high-risk patients, low-risk patients will receive negligibly or very modestly increased chances of survival with CABG, which is associated with short-term procedural risks when compared to PCI or medical therapy. Therefore, in low-risk patients, quality of life and patient preferences are given more weight than are strict clinical outcomes in the selection of treatment strategy.1
Given this, the AHA/CDC guidelines suggest that CABG should be limited to patients who have suitable coronary anatomy and who are not candidates for or have failed thrombolytic therapy/PTCA and who are within 4 to 6 hours of the onset of an MI.1,2

In the setting of cardiogenic shock complicating an acute MI, emergency CABG has been used after other interventions have failed or have not been indicated.2

Emergency CABG is indicated for most patients with acute MI who have persistent angina pectoris or hemodynamic instability following failed PTCA. CABG, optimally performed within 2 to 3 hours, can limit myocardial necrosis. However, mortality and morbidity rates exceed those for elective CABG, specifically when evaluating postoperative hemorrhage, the need for blood products and perioperative MI. Operative mortality is increased in patients with unstable hemodynamic status, myocardial ischemia, multivessel disease and prior CABG.2

Elective CABG after acute MI would be expected to improve long-term survival in patients with MI who have left main coronary artery stenosis greater than 50%, three-vessel disease, two-vessel disease with proximal left anterior descending coronary artery stenosis, or two-vessel disease not amenable to PTCA and reduced injection fraction. The optimal timing of surgery has not been established, although recent retrospective reports have suggested that elective CABG may be carried out 3 to 7 days after MI with operative mortality approaching that for elective CABG. Risk of operation is increased for patients with emergency or urgent surgery, older age, or ventricular function.2


References
 
© Siemens Healthcare Diagnostics Inc. 2007-2008 | Corporate Information | Privacy Policy | Terms of Use | Home | What's New | Glossary | Contact Us | Site Map | Site Index